Brown, MD, and Victoria Francois, MPH, discuss strategies to address the gap in sleep inequalities affecting Black women.

Metformin and SGLT2 inhibitors are associated with similar rates of incident gout among patients with type 2 diabetes.

Involvement of clinicians, including primary care physicians, endocrinologists, and rheumatologists, as appropriate, can ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

In a sudden about-face, HHS said it won't slash funding for the Women's Health Initiative, a major research project focused on preventing disease in older women.

Maternal hypertensive disorders of pregnancy are associated with adverse cognitive and language development in preterm infants at 2 years' corrected age.

Researchers have observed a decline in industry-sponsored post-approval clinical trials since the Inflation Reduction Act (IRA) was passed.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

The link between asthma and type 2 diabetes is not only due to BMI; shared environmental and genetic risk factors may also play a role.

HHS and the NIH announced "Generation Gold Standard," an initiative to develop next-generation, universal vaccines.

A scientific statement has been published by the American Heart Association regarding the effect of sleep health on cardiometabolic health.

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.